Free Trial
NASDAQ:VLON

Vallon Pharmaceuticals (VLON) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$2.46
$3.00
50-Day Range
$0.27
$2.87
52-Week Range
$0.21
$12.92
Volume
290,657 shs
Average Volume
5.78 million shs
Market Capitalization
$35.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VLON stock logo

About Vallon Pharmaceuticals Stock (NASDAQ:VLON)

Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The company is also developing ADMIR, an abuse deterrent formulation of methylphenidate for the treatment of ADHD. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania.

VLON Stock News Headlines

Questcor Pharmaceuticals,
Wall Street destroyed my wife’s retirement. Here’s how we saved it.
How we rebuilt my wife's retirement
Wall Street destroyed my wife’s retirement. Here’s how we saved it.
How we rebuilt my wife's retirement
Vallon Pharmaceuticals, Inc. (VLON)
See More Headlines
Receive VLON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vallon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
6/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VLON
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Net Income
$-7,020,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$100,000.00
Book Value
$0.18 per share

Miscellaneous

Free Float
8,453,000
Market Cap
$35.86 million
Optionable
Not Optionable
Beta
-1.14
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives


VLON Stock Analysis - Frequently Asked Questions

When did Vallon Pharmaceuticals' stock split?

Vallon Pharmaceuticals's stock reverse split on the morning of Monday, April 24th 2023. The 1-30 reverse split was announced on Monday, April 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, April 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

When did Vallon Pharmaceuticals IPO?

Vallon Pharmaceuticals (VLON) raised $15 million in an initial public offering on Wednesday, February 10th 2021. The company issued 1,700,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.

This page (NASDAQ:VLON) was last updated on 6/22/2024 by MarketBeat.com Staff

From Our Partners